LEADER 01403nas  22003973a 450 
001 9910142821603321
005 20240413014407.0
035   $a(CKB)1000000000531235
035   $a(CONSER)sn 97039449 
035   $a(DE-599)ZDB2059579-7
035   $a(EXLCZ)991000000000531235
100   $a19970915a199u9999  ua 
101 0 $aeng
135   $aurcnu|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCurrent problems in pharmacovigilance /$fCommittee on Safety of Medicines [and] Medicines Control Agency
210   $a[London $cThe Agency]
215   $a1 online resource
606   $aPharmacovigilance$vPeriodicals
606   $aDrug development$xStandards$vPeriodicals
606   $aDrugs$xQuality control$vPeriodicals
606   $aPharmaceutical Preparations$xadverse effects$vPeriodicals
615  0$aPharmacovigilance
615  0$aDrug development$xStandards
615  0$aDrugs$xQuality control
615 02$aPharmaceutical Preparations$xadverse effects
712 02$aGreat Britain.$bCommittee on Safety of Medicines.
712 02$aGreat Britain.$bMedicines Control Agency.
712 02$aGreat Britain.$bMedicines and Healthcare products Regulatory Agency.
906   $aJOURNAL
912   $a9910142821603321
920   $aexl_impl conversion
996   $aCurrent problems in pharmacovigilance$91965836
997   $aUNINA